West Pharmaceutical Services Other Current Assets 2010-2025 | WST

West Pharmaceutical Services other current assets from 2010 to 2025. Other current assets can be defined as field containing the sum of all current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
  • West Pharmaceutical Services other current assets for the quarter ending March 31, 2025 were $121M, a 11.81% decline year-over-year.
  • West Pharmaceutical Services other current assets for 2024 were $0.124B, a 8.69% decline from 2023.
  • West Pharmaceutical Services other current assets for 2023 were $0.136B, a 31.84% increase from 2022.
  • West Pharmaceutical Services other current assets for 2022 were $0.103B, a 8.04% decline from 2021.
West Pharmaceutical Services Annual Other Current Assets
(Millions of US $)
2024 $124
2023 $136
2022 $103
2021 $112
2020 $52
2019 $65
2018 $54
2017 $39
2016 $39
2015 $37
2014 $36
2013 $42
2012 $38
2011 $47
2010 $43
2009 $38
West Pharmaceutical Services Quarterly Other Current Assets
(Millions of US $)
2025-03-31 $121
2024-12-31 $124
2024-09-30 $134
2024-06-30 $138
2024-03-31 $137
2023-12-31 $136
2023-09-30 $123
2023-06-30 $94
2023-03-31 $91
2022-12-31 $103
2022-09-30 $106
2022-06-30 $113
2022-03-31 $108
2021-12-31 $112
2021-09-30 $80
2021-06-30 $75
2021-03-31 $67
2020-12-31 $52
2020-09-30 $51
2020-06-30 $49
2020-03-31 $58
2019-12-31 $65
2019-09-30 $62
2019-06-30 $55
2019-03-31 $58
2018-12-31 $54
2018-09-30 $43
2018-06-30 $37
2018-03-31 $38
2017-12-31 $39
2017-09-30 $40
2017-06-30 $38
2017-03-31 $46
2016-12-31 $39
2016-09-30 $42
2016-06-30 $40
2016-03-31 $49
2015-12-31 $37
2015-09-30 $34
2015-06-30 $34
2015-03-31 $36
2014-12-31 $36
2014-09-30 $33
2014-06-30 $44
2014-03-31 $44
2013-12-31 $42
2013-09-30 $30
2013-06-30 $34
2013-03-31 $35
2012-12-31 $38
2012-09-30 $36
2012-06-30 $33
2012-03-31 $35
2011-12-31 $47
2011-09-30 $65
2011-06-30 $62
2011-03-31 $57
2010-12-31 $43
2010-09-30 $45
2010-06-30 $40
2010-03-31 $40
2009-12-31 $38
2009-09-30 $37
2009-06-30 $32
2009-03-31 $30
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $14.979B $2.893B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $88.910B 21.47
Becton Dickinson (BDX) United States $49.385B 12.23
Cardinal Health (CAH) United States $36.396B 19.06
Straumann Holding AG (SAUHY) Switzerland $20.753B 0.00
Labcorp (LH) United States $20.246B 16.42
Cooper (COO) United States $15.859B 21.03
Align Technology (ALGN) United States $12.512B 24.84
Henry Schein (HSIC) United States $8.682B 14.89
Merit Medical Systems (MMSI) United States $5.621B 27.17
DENTSPLY SIRONA (XRAY) United States $3.159B 9.43
CONMED (CNMD) United States $1.734B 12.98
STAAR Surgical (STAA) United States $0.930B 0.00
Lifevantage (LFVN) United States $0.166B 17.14
Pro-Dex (PDEX) United States $0.149B 16.29